These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8998402)

  • 1. Neuropeptides and Alzheimer's disease.
    Gottfries CG; Frederiksen SO; Heilig M
    Eur Neuropsychopharmacol; 1995 Dec; 5(4):491-500. PubMed ID: 8998402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and neuropeptide alterations in Alzheimer's disease.
    Bissette G; Nemeroff CB
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():33A-34A. PubMed ID: 1354039
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropeptide changes in cortical and deep gray structures in Alzheimer's disease.
    Roeske LC; Auchus AP
    Rev Neurosci; 1995; 6(4):317-28. PubMed ID: 8845972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide changes in dementia: pathogenetic implications and diagnostic value.
    Valenti G
    Gerontology; 1996; 42(5):241-56. PubMed ID: 8940647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides in Alzheimer's disease. Clinical implications.
    Mazurek MF; Beal MF; Martin JB
    Neurol Clin; 1986 Nov; 4(4):753-68. PubMed ID: 3025582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities.
    Van Dam D; Van Dijck A; Janssen L; De Deyn PP
    Curr Alzheimer Res; 2013 Jun; 10(5):449-68. PubMed ID: 23627705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides and Alzheimer's disease.
    Husain MM; Nemeroff CB
    J Am Geriatr Soc; 1990 Aug; 38(8):918-25. PubMed ID: 2201715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: biological diagnosis.
    Ebinger G; Herregodts P; Michotte Y; Vanderheyden P; Vauqelin G
    Acta Neurol Belg; 1989; 89(3-4):132-4. PubMed ID: 2516958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides in Alzheimer's Disease: An Update.
    Petrella C; Di Certo MG; Barbato C; Gabanella F; Ralli M; Greco A; Possenti R; Severini C
    Curr Alzheimer Res; 2019; 16(6):544-558. PubMed ID: 31456515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and subcortical neuropeptides in Alzheimer's disease.
    Auchus AP; Green RC; Nemeroff CB
    Neurobiol Aging; 1994; 15(4):589-95. PubMed ID: 7969745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: a review of the literature and of current developments].
    van Gool WA; Bolhuis PA
    Tijdschr Gerontol Geriatr; 1992 Dec; 23(6):212-6. PubMed ID: 1362298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitters and neuropeptides in Alzheimer's disease.
    McDonald WM; Nemeroff CB
    Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
    Lawlor BA; Ryan TM; Bierer LM; Schmeidler J; Haroutunian V; Mohs R; Davis KL
    Biol Psychiatry; 1995 Jun; 37(12):895-6. PubMed ID: 7548465
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.
    Strac DS; Muck-Seler D; Pivac N
    Psychiatr Danub; 2015 Mar; 27(1):14-24. PubMed ID: 25751428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptidergic systems in plaques of Alzheimer's disease.
    Struble RG; Powers RE; Casanova MF; Kitt CA; Brown EC; Price DL
    J Neuropathol Exp Neurol; 1987 Sep; 46(5):567-84. PubMed ID: 2442313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.